CSL Limited (OTC:CSLLY) and Arcturus Therapeutics (NASDAQ:ARCT) announced the results of a Phase 3 head-to-head study of ARCT ...
Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared ...
Biotech company Regeneron Pharmaceuticals lost a bid on Friday to be held immune from allegations that it misused a patented ...
Updated COVID-19 vaccines from Pfizer and Moderna targeting the latest variants of the virus are being offered to some ...
Calgary Herald on MSN6h
Doctors, nurses could be left out of Alberta COVID and flu vaccination campaignFamily doctors and nurse practitioners were told in a recent memo shared by Alberta Health that they will not receive ...
Over the nearly five years since COVID first emerged, you'd be forgiven if you've lost track of the number of new variants we ...
A head-to-head study has revealed that CSL and Arcturus Therapeutic’s self-amplifying mRNA vaccine can maintain a stronger ...
AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...
CSL Ltd. (CMXHF.PK) and Arcturus Therapeutics Holdings Inc. (ARCT), Monday announced that self-amplifying or sa-mRNA COVID-19 vaccine ...
According to The People’s Vaccine Alliance, Comirnaty costs an estimated $1.18 per dose to produce. For over two years now, the US government has been running its public vaccination campaign ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback